Yang Song

Yang Song currently serves as a Director at Amgen since October 2023, following a tenure as Director at Horizon from November 2019 to October 2023. Prior experience includes roles as Associate Director at Horizon and Senior Research Scientist I at Gilead Sciences from January 2018 to November 2019, focusing on project representation and PBPK/PKPD modeling. Yang also worked as Scientist II at ChemoCentryx, where responsibilities included clinical pharmacology and DMPK for Avacopan and CCX140. Initial experience involves a Summer Internship at Genentech and serving as a Graduate Assistant at the University of Illinois at Chicago. Educational qualifications include a Master's degree in Pharmacometrics from the University of Maryland Baltimore, a Ph.D. in Drug Metabolism and Anti-infection Drug Discovery from the University of Illinois Chicago, a Master's in Pharmacology from Peking Union Medical College, and a BS in Pharmacology from China Pharmaceutical University. Additionally, Yang has participated in a PK workshop at UCSF.